Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
2023-08-05 07:21:02 ET Merck KGaA (MKGAF) Q2 2023 Earnings Conference Call August 3, 2023 8:00 a.m. ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chief Executive Officer Helene von Roeder - Chief Financial Officer Ma...
2023-08-03 13:23:06 ET Merck KGaA press release ( OTCPK:MKGAF ): Q2 EBITDA of €1.6B. Net sales decrease by −1.1% to €5.3B. Updated forecast for fiscal 2023 • Net sales: Organic development between −2% and +2 % • Net sales excl...
2023-07-26 15:04:29 ET The World Health Organization updated its Essential Medicines List on Wednesday without adding a class of weight loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists as a treatment for obesity. The list designed to guide state procurement deci...
2023-07-16 20:14:12 ET UK-based HSBC initiated coverage of 19 major biopharma stocks this past week, labeling Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ), Merck KGaA ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) and Lonza ( OTCPK:LZAGY ) ( OTCPK:LZAGF ) as potential comeback stories, wh...
2023-07-14 11:30:36 ET Maravai LifeSciences ( NASDAQ: MRVI ) rose 3.4% amid a report that Germany's Merck KGaA ( OTCPK:MKGAF ) is speculated to be one of the companies looking at the vaccine reagent vendor. Merck ( OTCPK:MKGAF ) is rumored to have shown some int...
Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance PR Newswire Athinia ™ platform enables limitless analytics capabilities, including sophisticated AI and machin...
2023-06-30 11:57:31 ET Abcam ( NASDAQ: ABCM ) ADRs rose 4% on a report that the biotechnology supplier is seeing initial interest from Danaher ( DHR ) and Agilent Technologies ( A ). Abcam ( ABCM ) has also separately reached out to other companies, including G...
New silicon dielectrics processed via low-temperature Plasma Enhanced - Atomic Layer Deposition (ALD) technology enables flexible OLEDs in superior display devices. Provides highly improved barrier characteristics: 100 times more effective and 20 times thinner than existing solutions. Wins Displa...
2023-05-26 14:01:57 ET Oncolytics Biotech ( NASDAQ: ONCY ) shed ~16% on Friday after announcing results from its Phase 2 trial for experimental therapy pelareorep as a combination regimen in patients with a certain type of breast cancer. Results shared ahead of a presentatio...
2023-05-25 19:36:30 ET Summary It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS could generate sales of $6.3 billion by 2030. Roche Holding AG reported positive results reported from ...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...